SCHEMBL12957073

SCHEMBL12957073

Bc1cnn(C2CCCCO2)c(=O)c1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ CYP4F2 P78329 4/20 0.37
▸ CYP4A11 Q02928 4/20 0.37
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ RXRG P48443 1/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MEN1 O00255 1/20 0.34
▸ KAT2B Q92831 1/20 0.34
▸ GAA P10253 1/20 0.33
▸ KDM5B Q9UGL1 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ RET P07949 1/20 0.32
▸ ACVRL1 P37023 1/20 0.31
▸ ACVR1 Q04771 1/20 0.31
▸ ATR Q13535 1/20 0.31
▸ CNR1 P21554 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2896462 0.85 ALDH1A1 (0.48) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL8242935 0.80 ALDH1A1 (0.43) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL3717759 0.75 CYP4F2 (0.44) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL23933195 0.74 LMNA (0.38) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL23933193 0.74 LMNA (0.38) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL1008524 0.74 ALDH1A1 (0.48) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL12085240 0.74 ALDH1A1 (0.48) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL25795329 0.74 RXRA (0.46) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL31641559 0.73 ALDH1A1 (0.47) ALDH1A1POLBLMNACYP4F2CYP4A11
SCHEMBL14903852 0.72 CYP4F2 (0.47) ALDH1A1POLBLMNACYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966220-B1 MGLUR1 ANATGONISTS AS THERAPEUTIC AGENTS SCHERING CORP (US) 2011-01-26 — — EP disclosed
Send feedback